Putative biomarkers and targets of estrogen receptor negative human breast cancer

International Journal of Molecular Sciences

Volumn 12, Issue 7, 2011, Pages 4504-4521

  Sahab, Ziad J ^a   Man, Yan Gao ^b,c   Byers, Stephen W ^a   Sang, Qing Xiang A ^d  

^a GEORGETOWN UNIVERSITY   (United States)

^b Diagnostic and Translational Research Center   (United States)

^c JILIN UNIVERSITY   (China)

^d FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Biomarker; Breast cancer; Chromatography; DCIS; Electrophoresis; Estrogen receptor; Metastasis; Proteomics

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; BETA TUBULIN; BIOLOGICAL MARKER; CA 15-3 ANTIGEN; CALCIUM BINDING PROTEIN; CHEMOKINE RECEPTOR CXCR4; CYTOKERATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GALECTIN 1; IMETELSTAT; IMMUNOPHILIN; LAMIN A; MICRORNA; NUCLEOSIDE DIPHOSPHATE KINASE A; PACLITAXEL; PROGESTERONE RECEPTOR; RALA BINDING PROTEIN; RAS PROTEIN; RETINOIC ACID BINDING PROTEIN; S100 CALCIUM BINDING PROTEIN A11; SUPEROXIDE DISMUTASE; TRASTUZUMAB; UNCLASSIFIED DRUG; URIDINE PHOSPHORYLASE; VINBLASTINE; VINCRISTINE; ESTROGEN RECEPTOR; TUMOR MARKER;

BREAST CANCER; CANCER CELL; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CELL RENEWAL; CYTOSKELETON; DRUG TARGETING; EARLY DIAGNOSIS; FOOD AND DRUG ADMINISTRATION; HUMAN; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; METASTASIS POTENTIAL; MICROTUBULE; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; RELIABILITY; REVIEW; TRIPLE NEGATIVE BREAST CANCER; BREAST TUMOR; FEMALE; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; CYTOSKELETON; FEMALE; HUMANS; NEOPLASTIC STEM CELLS; RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 79960816795     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12074504     Document Type: Review

References (158)

1. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57-70.
2. Wiesner, A. Detection of tumor markers with ProteinChip(R) technology. Curr. Pharm. Biotechnol. 2004, 5, 45-67.
3. Sahab, Z.J.; Man, Y.G.; Semaan, S.M.; Newcomer, R.G.; Byers, S.W.; Sang, Q.X.A. Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype. Clin. Exp. Metastasis 2010, 27, 493-503.
4. Wulfkuhle, J.D.; Sgroi, D.C.; Krutzsch, H.; McLean, K.; McGarvey, K.; Knowlton, M.; Chen, S.; Shu, H.J.; Sahin, A.; Kurek, R.; et al. Proteomics of human breast ductal carcinoma in situ. Cancer Res. 2002, 62, 6740-6749.
5. Hsiao, Y.S.; Chou, M.C.; Fowler, C.; Mason, J.T.; Man, Y.G. Breast cancer heterogeneity: Mechanisms, proofs, and implications. J. Cancer 2010, 1, 6-13.
6. Chan, K.; Ng, T.B. Lectin glycoarray technologies for nanoscale biomedical detection. Protein Pept. Lett. 2010, 17, 1417-1425.
7. Choi, S.; Goryll, M.; Sin, L.Y.M.; Wong, P.K.; Chae, J. Microfluidic-based biosensors toward point-of-care detection of nucleic acids and proteins. Microfluid. Nanofluid. 2011, 10, 231-247.
8. Gemeiner, P.; Mislovicova, D.; Tkac, J.; Svitel, J.; Patoprsty, V.; Hrabarova, E.; Kogan, G.; Kozar, T. Lectinomics II. A highway to biomedical/clinical diagnostics. Biotechnol. Adv. 2009, 27, 1-15.
9. Liu, X.; Dai, Q.; Austin, L.; Coutts, J.; Huo, Q. Gold nanoparticle bioconjugates for biomolecular imaging and detection. Nanotech 2008, 2, 256-258.
10. Liu, X.; Huo, Q. A washing-free and amplification-free one-step homogeneous assay for protein detection using gold nanoparticle probes and dynamic light scattering. J. Immunol. Methods 2009, 349, 38-44.
11. Liu, X.; Dai, Q.; Austin, L.; Coutts, J.; Knowles, G.; Zou, J.H.; Chen, H.; Huo, Q. A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J. Am. Chem. Soc. 2008, 130, 2780-2782.
12. Marco-Ramell, A.; Bassols, A. Enrichment of low-abundance proteins from bovine and porcine serum samples for proteomic studies. Res. Vet. Sci. 2010, 89, 340-343.
13. Nissum, M.; Foucher, A.L. Analysis of human plasma proteins: A focus on sample collection and separation using free-flow electrophoresis. Expert Rev. Proteomics 2008, 5, 571-587.
14. Pujia, A.; De Angelis, F.; Scumaci, D.; Gaspari, M.; Liberale, C.; Candeloro, P.; Cuda, G.; Di Fabrizio, E. Highly efficient human serum filtration with water-soluble nanoporous nanoparticles. Int. J. Nanomed. 2010, 5, 1005-1015.
15. Shen, H.; Li, X.; Bieberich, C.; Frey, D.D. Serial displacement chromatofocusing and its applications in multidimensional chromatography and gel electrophoresis: II. Experimental results. J. Chromatogr. A 2009, 1216, 977-984.
16. Stempfer, R.; Kubicek, M.; Lang, I.M.; Christa, N.; Gerner, C. Quantitative assessment of human serum high-abundance protein depletion. Electrophoresis 2008, 29, 4316-4323.
17. Xu, X.; Veenstra, T.D. Analysis of biofluids for biomarker research. Proteomics Clin. Appl. 2008, 2, 1403-1412.
18. Sahab, Z.J.; Semaan, S.M.; Sang, Q.X.A. Methodology and applications of disease biomarker identification in human serum. Biomarker Insights 2007, 2, 21-43.
19. Sahab, Z.J.; Suh, Y.; Sang, Q.X.A. Isoelectric point-based prefractionation of proteins from crude biological samples prior to two-dimensional gel electrophoresis. J. Proteome Res. 2005, 4, 2266-2272.
20. Sahab, Z.J.; Iczkowski, K.A.; Sang, Q.X.A. Anion exchange fractionation of serum proteins versus albumin elimination. Anal. Biochem. 2007, 368, 24-32.
21. Wu, H.; Huo, Q.S.; Varnum, S.; Wang, J.; Liu, G.G.; Nie, Z.M.; Liu, J.; Lin, Y.H. Dye-doped silica nanoparticle labels/protein microarray for detection of protein biomarkers. Analyst 2008, 133, 1550-1555.
22. Gustafsson, J.A. Estrogen receptor beta-A new dimension in estrogen mechanism of action. J. Endocrinol. 1999, 163, 379-383.
23. Green, S.; Walter, P.; Kumar, V.; Krust, A.; Bornert, J.M.; Argos, P.; Chambon, P. Human estrogen-receptor Cdna-Sequence, expression and homology to V-Erb-A. Nature 1986, 320, 134-139.
24. Greene, G.L.; Gilna, P.; Waterfield, M.; Baker, A.; Hort, Y.; Shine, J. Sequence and expression of human estrogen-receptor complementary-DNA. Science 1986, 231, 1150-1154.
25. Kuiper, G.; Enmark, E.; PeltoHuikko, M.; Nilsson, S.; Gustafsson, J.A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 1996, 93, 5925-5930.
26. Mosselman, S.; Polman, J.; Dijkema, R. ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996, 392, 49-53.
27. Tong, D.; Schuster, E.; Seifert, M.; Czerwenka, K.; Leodolter, S.; Zeillinger, R. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines. Breast Cancer Res. Treat. 2002, 71, 249-255.
28. Hall, J.M.; McDonnell, D.P. The estrogen receptor beta-isoform (ER beta) of the human estrogen receptor modulates ER alpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999, 140, 5566-5578.
29. Wang, Z.Z.; Li, Y.; Ai, C.Z.; Wang, Y.H. In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-Arylnaphthalenes and 2-Arylquinolines. Int. J. Mol. Sci. 2010, 11, 3434-3458.
30. Pettersson, K.; Delaunay, F.; Gustafsson, J.A. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000, 19, 4970-4978.
31. Paruthiyil, S.; Parmar, H.; Kerekatte, V.; Cunha, G.R.; Firestone, G.L.; Leitman, D.C. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G(2) cell cycle arrest. Cancer Res. 2004, 64, 423-428.
32. Couse, J.F.; Korach, K.S. Estrogen receptor null mice: What have we learned and where will they lead us? Endocr. Rev. 1999, 20, 459-459.
33. Bocchinfuso, W.P.; Lindzey, J.K.; Hewitt, S.C.; Clark, J.A.; Myers, P.H.; Cooper, R.; Korach, K.S. Induction of mammary gland development in estrogen receptor-alpha knockout mice. Endocrinology 2000, 141, 2982-2994.
34. Krege, J.H.; Hodgin, J.B.; Couse, J.F.; Enmark, E.; Warner, M.; Mahler, J.F.; Sar, M.; Korach, K.S.; Gustafsson, J.A.; Smithies, O. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. USA 1998, 95, 15677-15682.
35. An, J.P.; Tzagarakis-Foster, C.; Scharschmidt, T.C.; Lomri, N.; Leitman, D.C. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J. Biol. Chem. 2001, 276, 17808-17814.
36. Oesterreich, S.; Zhang, P.; Guler, R.L.; Sun, X.H.; Curran, E.M.; Welshons, W.V.; Osborne, C.K.; Lee, A.V. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res. 2001, 61, 5771-5777.
37. Liu, M.M.; Albanese, C.; Anderson, C.M.; Hilty, K.; Webb, P.; Uht, R.M.; Price, R.H.; Pestell, R.G.; Kushner, P.J. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J. Biol. Chem. 2002, 277, 24353-24360.
38. Strom, A.; Hartman, J.; Foster, J.S.; Kietz, S.; Wimalasena, J.; Gustafsson, J.A. Estrogen receptor beta inhibits 17 beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc. Natl. Acad. Sci. USA 2004, 101, 1566-1571.
39. Lazennec, G.; Bresson, D.; Lucas, A.; Chauveau, C.; Vignon, F. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001, 142, 4120-4130.
40. Skliris, G.P.; Munot, K.; Bell, S.M.; Carder, P.J.; Lane, S.; Horgan, K.; Lansdown, M.R.J.; Parkes, A.T.; Hanby, A.M.; Markham, A.F.; et al. Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J. Pathol. 2003, 201, 213-220.
41. Roger, P.; Sahla, M.E.; Makela, S.; Gustafsson, J.A.; Baldet, P.; Rochefort, H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 2001, 61, 2537-2541.
42. Park, B.W.; Kim, K.S.; Heo, M.K.; Ko, S.S.; Hong, S.W.; Yang, W.I.; Kim, J.H.; Kim, G.E.; Lee, K.S. Expression of estrogen receptor-beta in normal mammary and tumor tissues: Is it protective in breast carcinogenesis? Breast Cancer Res. Treat. 2003, 80, 79-85.
43. Man, Y.G.; Tai, L.; Barner, R.; Vang, R.; Saenger, J.S.; Shekitka, K.M.; Bratthauer, G.L.; Wheeler, D.T.; Liang, C.Y.; Vinh, T.N.; Strauss, B.L. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: Implications for tumor progression and invasion. Breast Cancer Res. 2003, 5, R231-R241.
44. Al-Hajj, M.; Clarke, M.F. Self-renewal and solid tumor stem cells. Oncogene 2004, 23, 7274-7282.
45. Al-Hajj, M.; Becker, M.W.; Wichal, M.; Weissman, I.; Clarke, M.F. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 2004, 14, 43-47.
46. Munzone, E.; Curigliano, G.; Rocca, A.; Bonizzi, G.; Renne, G.; Goldhirsch, A.; Nole, F. Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy. Breast Cancer Res. 2006, 8, R4:1-R4:4.
47. Clarke, R.B.; Spence, K.; Anderson, E.; Howell, A.; Okano, H.; Potten, C.S. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev. Biol. 2005, 277, 443-456.
48. Man, Y.G. Aberrant leukocyte infiltration: A direct trigger for breast tumor invasion and metastasis. Int. J. Biol. Sci. 2010, 6, 129-132.
49. Man, Y.G. Tumor cell budding from focally disrupted tumor capsules: A common pathway for all breast cancer subtype derived invasion? J. Cancer 2010, 1, 32-37.
50. Man, Y.G.; Mason, J.; Vinh, T.N.; Zhang, S.M.; Stamatakos, M.D. Focal myoepithelial cell layer disruptions and basement membrane disappearance are correlated events: Implications for breast tumor invasion. FASEB J. 2007, 21, A386-A386.
51. Man, Y.G.; Sang, Q.X.A. The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: A paradigm shift from the protease-centered hypothesis. Exp. Cell Res. 2004, 301, 103-118.
52. Man, Y.G.; Shekitka, K.M.; Bratthauer, G.L.; Tavassoli, F.A. Immunohistochemical and genetic alterations in mammary epithelial cells immediately overlying focally disrupted myoepithelial cell layers. Breast Cancer Res. Treat. 2002, 76, S143.
53. Man, Y.G.; Shen, T.; Weisz, J.; Berg, P.E.; Schwartz, A.M.; Mulshine, J.L.; Sang, Q.X.; Nieburgs, H.E. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect. Prev. 2005, 29, 323-331.
54. Man, Y.G.; Zhang, Y.; Shen, T.; Zeng, X.; Tauler, J.; Mulshine, J.L.; Strauss, B.L. cDNA expression profiling reveals elevated gene expression in cell clusters overlying focally disrupted myoepithelial cell layers: Implications for breast tumor invasion. Breast Cancer Res. Treat. 2005, 89, 199-208.
55. Zhang, C.L.; Mori, M.; Gao, S.L.; Li, A.M.; Hoshino, I.; Aupperlee, M.D.; Haslam, S.Z.; Xiao, H. Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors. Cancer Res. 2010, 70, 10224-10233.
56. Simonini, P.D.R.; Breiling, A.; Gupta, N.; Malekpour, M.; Youns, M.; Omranipour, R.; Malekpour, F.; Volinia, S.; Croce, C.M.; Najmabadi, H.; et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res. 2010, 70, 9175-9184.
57. Yang, J.; Jubb, A.M.; Pike, L.; Buffa, F.M.; Turley, H.; Baban, D.; Leek, R.; Gatter, K.C.; Ragoussis, J.; Harris, A.L. The Histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Res. 2010, 70, 6456-6466.
58. Li, L.; Lu, Y. Inhibition of hypoxia-induced cell motility by p16 in MDA-MB-231 breast cancer cells. J. Cancer 2010, 1, 126-135.
59. Parra-Palau, J.L.; Pedersen, K.; Peg, V.; Scaltriti, M.; Angelini, P.D.; Escorihuela, M.; Mancilla, S.; Pla, A.S.; Cajal, S.R.Y.; Baselga, J.; et al. A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-Positive breast cancers. Cancer Res. 2010, 70, 8537-8546.
60. Diaz-Cruz, E.S.; Furth, P.A. Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia. Cancer Res. 2010, 70, 3965-3974.
61. McKeen, H.D.; Byrne, C.; Jithesh, P.V.; Donley, C.; Valentine, A.; Yakkundi, A.; O'Rourke, M.; Swanton, C.; McCarthy, H.O.; Hirst, D.G.; et al. FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy. Cancer Res. 2010, 70, 1090-1100.
62. Ronneberg, J. A.; Fleischer, T.; Solvang, H. K.; Nordgard, S. H.; Edvardsen, H.; Potapenko, I.; Nebdal, D.; Daviaud, C.; Gut, I.; Bukholm, I.; et al. Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer. Mol. Oncol. 2011, 5, 61-76.
63. Rhodes, L.V.; Short, S.P.; Neel, N.F.; Salvo, V.A.; Zhu, Y.; Elliott, S.; Wei, Y.K.; Yu, D.H.; Sun, M.H.; Muir, S.E.; et al. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res. 2011, 71, 603-613.
64. Duangmano, S.; Dakeng, S.; Jiratchariyakul, W.; Suksamrarn, A.; Smith, D.R.; Patmasiriwat, P. Antiproliferative effects of cucurbitacin B in breast cancer cells: Down-regulation of the c-Myc/hTERT/Telomerase pathway and obstruction of the cell cycle. Int. J. Mol. Sci. 2010, 11, 5323-5338.
65. Shukla, V.; Coumoul, X.; Lahusen, T.; Wang, R.H.; Xu, X.L.; Vassilopoulos, A.; Xiao, C.Y.; Lee, M.H.; Man, Y.G.; Ouchi, M.; et al. BRCA1 affects global DNA methylation through regulation of DNMT1. Cell Res. 2010, 20, 1201-1215.
66. Hsiao, Y.H.; Su, Y.A.; Tsai, H.D.; Mason, J.T.; Chou, M.C.; Man, Y.G. Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression. Int. J. Biol. Sci. 2010, 6, 428-442.
67. Man, Y.G.; Harley, R.; Mason, J.; Gardner, W.A. Contributions of leukocytes to tumor invasion and metastasis: The piggy-back hypothesis. Cancer Epidemiol. 2010, 34, 3-6.
68. Kluk, B.J.; Fu, Y.B.; Formolo, T.A.; Zhang, L.; Hindle, A.K.; Man, Y.G.; Siegel, R.S.; Berg, P.E.; Deng, C.X.; McCaffrey, T.A.; Fu, S.W. BP1, an isoform of DLX4 homeoprotein, negatively regulates BRCA1 in sporadic breast cancer. Int. J. Biol. Sci. 2010, 6, 513-524.
69. O'Brien, J.; Lyons, T.; Monks, J.; Lucia, M.S.; Wilson, R.S.; Hines, L.; Man, Y.G.; Borges, V.; Schedin, P. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am. J. Pathol. 2010, 176, 1241-1255.
70. Sahab, Z.J.; Hall, M.D.; Sung, Y.M.; Dakshanamurthy, S.; Ji, Y.; Kumar, D.; Byers, S.W. Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the a-tubulin tyrosination cycle. Cancer Res. 2011, 71, 1219-1228.
71. Sahab, Z.J.; Hall, M.D.; Zhang, L.; Cheema, A.; Byers, S.W. Tumor suppressor RARRES1 regulates DLG2, PP2A, VCP, EB1, and Ankrd26. J. Cancer 2010, 1, 14-22.
72. Fu, Y.; Lian, Y.; Kim, K.S.; Zhang, L.; Hindle, A.K.; Brody, F.; Siegel, R.S.; McCaffrey, T.A.; SW, F. BP1 homeoprotein enhances metastatic potential in er-negative breast cancer. J. Cancer 2010, 1, 54-62.
73. Briehl, M.M.; Baker, A.F.; Siemankowski, L.M.; Morreale, J. Modulation of antioxidant defenses during apoptosis. Oncol. Res. 1997, 9, 281-285.
74. Tchevkina, E.; Agapova, L.; Dyakova, N.; Martinjuk, A.; Komelkov, A.; Tatosyan, A. The small G-protein RalA stimulates metastasis of transformed cells. Oncogene 2005, 24, 329-335.
75. Ward, Y.; Wang, W.; Woodhouse, E.; Linnoila, I.; Liotta, L.; Kelly, K. Signal pathways which promote invasion and metastasis: Critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol. Cell. Biol. 2001, 21, 5958-5969.
76. Wells, V.; Davies, D.; Mallucci, L. Cell cycle arrest and induction of apoptosis by beta galactoside binding protein (beta GBP) in human mammary cancer cells. A potential new approach to cancer control. Eur. J. Cancer 1999, 35, 978-983.
77. Cao, D.L.; Russell, R.L.; Zhang, D.K.; Leffert, J.J.; Pizzorno, G. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines. Cancer Res. 2002, 62, 2313-2317.
78. Dong, D.; Ruuska, S.E.; Levinthal, D.J.; Noy, N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J. Biol. Chem. 1999, 274, 23695-23698.
79. Kondo, A.; Sakaguchi, M.; Makino, E.; Namba, M.; Okada, S.; Huh, N.H. Localization of S100C immunoreactivity in various human tissues. Acta Med. Okayama 2002, 56, 31-34.
80. Oue, N.; Hamai, Y.; Mitani, Y.; Matsumura, S.; Oshimo, Y.; Aung, P.P.; Kuraoka, K.; Nakayama, H.; Yasui, W. Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res. 2004, 64, 2397-2405.
81. Steeg, P.S.; Bevilacqua, G.; Kopper, L.; Thorgeirsson, U.P.; Talmadge, J.E.; Liotta, L.A.; Sobel, M.E. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst. 1988, 80, 200-204.
82. Leone, A.; Flatow, U.; King, C.R.; Sandeen, M.A.; Margulies, I.M.K.; Liotta, L.A.; Steeg, P.S. Reduced tumor-incidence, metastatic potential, and cytokine responsiveness of Nm23-transfected melanoma-cells. Cell 1991, 65, 25-35.
83. Zhang, B.L.; Zhang, Y.Q.; Dagher, M.C.; Shacter, E. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res. 2005, 65, 6054-6062.
84. Sasaki, T.; Takai, Y. The Rho small G protein family Rho GDI system as a temporal and spatial determinant for cytoskeletal control. Biochem. Biophys. Res. Commun. 1998, 245, 641-645.
85. Olofsson, B. Rho guanine dissociation inhibitors: Pivotal molecules in cellular signalling. Cell Signal. 1999, 11, 545-554.
86. Grudzien, P.; Lo, S.; Albain, K.S.; Robinson, P.; Rajan, P.; Strack, P.R.; Golde, T.E.; Miele, L.; Foreman, K.E. Inhibition of notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Res. 2010, 30, 3853-3867.
87. Joseph, I.; Tressler, R.; Bassett, E.; Harley, C.; Buseman, C.M.; Pattamatta, P.; Wright, W.E.; Shay, J.W.; Go, N.F. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Cancer Res. 2010, 70, 9494-9504.
88. Dontu, G.; Al-Hajj, M.; Abdallah, W.A.; Clarke, M.F.; Wicha, M.S. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003, 36, 59-72.
89. Dontu, G.; Ginestier, C.; Jauffret, E.; Wicha, M. Breast cancer stem cells: Biological and clinical implications. Tumor Biol. 2007, 28, 54-54.
90. Sell, S.; Pierce, G.B. Maturation arrest of stem-cell differentiation is a common pathway for the cellular-origin of teratocarcinomas and epithelial cancers. Lab. Invest. 1994, 70, 6-22.
91. Kordon, E.C.; Smith, G.H. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998, 125, 1921-1930.
92. Chepko, G.; Smith, G.H. Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell 1997, 29, 239-253.
93. Dick, J.E. Breast cancer stem cells revealed. Proc. Natl. Acad. Sci. USA 2003, 100, 3547-3549.
94. Peled, A.; Petit, I.; Kollet, O.; Magid, M.; Ponomaryov, T.; Byk, T.; Nagler, A.; Ben-Hur, H.; Many, A.; Shultz, L.; et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283, 845-848.
95. Muller, A.; Homey, B.; Soto, H.; Ge, N.F.; Catron, D.; Buchanan, M.E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S.N.; et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410, 50-56.
96. Tu, S.M.; Lin, S.H.; Logothetis, C.J. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol. 2002, 3, 508-513.
97. Pechoux, C.; Gudjonsson, T.; Ronnov-Jessen, L.; Bissell, M.J.; Petersen, O.W. Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev. Biol. 1999, 206, 88-99.
98. Al-Hajj, M.; Wicha, M.S.; Benito-Hernandez, A.; Morrison, S.J.; Clarke, M.F. Prospective identification of tumorigenic breast cancer cells (vol 100, pg 3983, 2003). Proc. Natl. Acad. Sci. USA 2003, 100, 6890-6890.
99. Stingl, J.; Eaves, C.J., Zandieh, I.; Emerman, J.T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 2001, 67, 93-109.
100. Gudjonsson, T.; Ronnov-Jessen, L.; Villadsen, R.; Rank, F.; Bissell, M.J.; Petersen, O.W. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J. Cell Sci. 2002, 115, 39-50.
101. Welm, B.E.; Tepera, S.B.; Venezia, T.; Graubert, T.A.; Rosen, J. M.; Goodell, M.A. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 2002, 245, 42-56.
102. Al-Hajj, M.; Wicha, M.S.; Benito-Hernandez, A.; Morrison, S.J.; Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100, 3983-3988.
103. Lengerke, C.; Fehm, T.; Kurth, R.; Neubauer, H.; Scheble, V.; Muller, F.; Schneider, F.; Petersen, K.; Wallwiener, D.; Kanz, L., et al. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 2011, 11, 42.
104. Subramanian, R.; Wilson-Kubalek, E.M.; Arthur, C.P.; Bick, M.J.; Campbell, E.A.; Darst, S.A.; Milligan, R.A.; Kapoor, T.M. Insights into antiparallel microtubule crosslinking by PRC1, a conserved nonmotor microtubule binding protein. Cell 2010, 142, 433-443.
105. Walczak, C.E.; Shaw, S.L. A map for bundling microtubules. Cell 2010, 142, 364-367.
106. Li, X.; Kapoor, T.M. Approach to profile proteins that recognize post-translationally modified histone tails. J. Am. Chem. Soc. 2010, 132, 2504-2505.
107. Mullins, R.D. Cytoskeletal mechanisms for breaking cellular symmetry. Cold Spring Harbor Perspect. Biol. 2010, 2, a003392.
108. Luxton, G.W.G.; Gomes, E.R.; Folker, E.S.; Vintinner, E.; Gundersen, G.G. Linear arrays of nuclear envelope proteins harness retrograde actin flow for nuclear movement. Science 2010, 329, 956-959.
109. Wuhr, M.; Tan, E.S.; Parker, S.K.; Detrich, H.W.; Mitchison, T.J. A model for cleavage plane determination in early amphibian and fish embryos. Curr. Biol. 2010, 20, 2040-2045.
110. Folker, E.S.; Ostlund, C.; Luxton, G.W.G.; Worman, H.J.; Gundersen, G.G. Lamin A variants that cause striated muscle disease are defective in anchoring transmembrane actin-associated nuclear lines for nuclear movement. Proc. Natl. Acad. Sci. USA 2011, 108, 131-136.
111. Hansen, S.D.; Mullins, R.D. VASP is a processive actin polymerase that requires monomeric actin for barbed end association. J. Cell Biol. 2010, 191, 571-584.
112. Kueh, H.Y.; Brieher, W.M.; Mitchison, T.J. Quantitative analysis of actin turnover in listeria comet tails: Evidence for catastrophic filament turnover. Biophys. J. 2010, 99, 2153-2162.
113. Jin, Y.; Eves, P.T.; Tang, F.; Weisman, L.S. PTC1 is required for vacuole inheritance and promotes the association of the myosin-v vacuole-specific receptor complex. Mol. Biol. Cell 2009, 20, 1312-1323.
114. Levi, S.K.; Bhattacharyya, D.; Strack, R.L.; Austin, J.R.; Glick, B.S. The yeast GRASP Grh1 colocalizes with COPII and is dispensable for organizing the secretory pathway. Traffic 2010, 11, 1168-1179.
115. Cheli, V.T.; Daniels, R.W.; Godoy, R.; Hoyle, D.J.; Kandachar, V.; Starcevic, M.; Martinez-Agosto, J.A.; Poole, S.; DiAntonio, A.; Lloyd, V.K., et al Genetic modifiers of abnormal organelle biogenesis in a Drosophila model of BLOC-1 deficiency. Hum. Mol. Genet. 2010, 19, 861-878.
116. Cheli, V.T.; Dell'Angelica, E.C. Early origin of genes encoding subunits of biogenesis of lysosome-related organelles complex-1, -2 and -3. Traffic 2010, 11, 579-586.
117. Gurland, G.; Gundersen, G.G. Stable, detyrosinated microtubules function to localize vimentin intermediate filaments in fibroblasts. J. Cell Biol. 1995, 131, 1275-1290.
118. Lin, S.X.; Gundersen, G.G.; Maxfield, F.R. Export from pericentriolar endocytic recycling compartment to cell surface depends on stable, detyrosinated (Glu) microtubules and kinesin. Mol. Biol. Cell 2002, 13, 96-109.
119. Tran, A.D.A.; Marmo, T.P.; Salam, A.A.; Che, S.; Finkelstein, E.; Kabarriti, R.; Xenias, H.S.; Mazitschek, R.; Hubbert, C.; Kawaguchi, Y., et al. HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions. J. Cell Sci. 2007, 120, 1469-1479.
120. Matrone, M.A.; Whipple, R.A.; Balzer, E.M.; Martin, S.S. Microtentacles tip the balance of cytoskeletal forces in circulating tumor cells. Cancer Res. 2010, 70, 7737-7741.
121. Whipple, R.A.; Matrone, M.A.; Cho, E.H.; Balzer, E.M.; Vitolo, M.I.; Yoon, J.R.; Ioffe, O.B.; Tuttle, K.C.; Yang, J.; Martin, S.S. Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement. Cancer Res. 2010, 70, 8127-8137.
122. Sawin, K.E.; Mitchison, T.J. Mutations in the kinesin-like protein Eg5 disrupting localization to the mitotic spindle. Proc. Natl. Acad. Sci. USA 1995, 92, 4289-4293.
123. Sauer, G.; Korner, R.; Hanisch, A.; Ries, A.; Nigg, E.A.; Sillje, H.H.W. Proteome analysis of the human mitotic spindle. Mol. Cell. Proteomics 2005, 4, 35-43.
124. Yamada, J.; Phillips, J.L.; Patel, S.; Goldfien, G.; Calestagne-Morelli, A.; Huang, H.; Reza, R.; Acheson, J.; Krishnan, V.V.; Newsam, S., et al. A bimodal distribution of two distinct categories of intrinsically disordered structures with separate functions in FG nucleoporins. Mol. Cell. Proteomics 2010, 9, 2205-2224.
125. Jin, N.; Chow, C.Y.; Liu, L.; Zolov, S.N.; Bronson, R.; Davisson, M.; Petersen, J.L.; Zhang, Y.L.; Park, S.; Duex, J.E., et al. VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P-2 in yeast and mouse. EMBO J. 2008, 27, 3221-3234.
126. Ban, T.; Heymann, J.A.W.; Song, Z.Y.; Hinshaw, J.E.; Chan, D.C. OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation. Hum. Mol. Genet. 2010, 19, 2113-2122.
127. Chen, H.C.; Vermulst, M.; Wang, Y.E.; Chomyn, A.; Prolla, T.A.; McCaffery, J.M.; Chan, D.C. Mitochondrial fusion is required for mtdna stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010, 141, 280-289.
128. Chen, H.C.; Chan, D.C. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum. Mol. Genet. 2009, 18, R169-R176.
129. Bouck, D.C.; Joglekar, A.P.; Bloom, K.S. Design features of a mitotic spindle: Balancing tension and compression at a single microtubule kinetochore interface in budding yeast. Annu. Rev. Genet. 2008, 42, 335-359.
130. Joglekar, A.P.; Bouck, D.; Finley, K.; Liu, X.K.; Wan, Y.K.; Berman, J.; He, X.W.; Salmon, E.D.; Bloom, K.S. Molecular architecture of the kinetochore-microtubule attachment site is conserved between point and regional centromeres. J. Cell Biol. 2008, 181, 587-594.
131. Joglekar, A.P.; Bloom, K.S.; Salmon, E.D. Mechanisms of force generation by end-on kinetochore-microtubule attachments. Curr. Opin. Cell Biol. 2010, 22, 57-67.
132. Bartolini, F.; Gundersen, G.G. Formins and microtubules. Biochim. Et Biophys. Acta-Mol. Cell Res. 2010, 1803, 164-173.
133. Bayly, P.V.; Lewis, B.L.; Kemp, P.S.; Pless, R.B.; Dutcher, S.K. Efficient spatiotemporal analysis of the flagellar waveform of Chlamydomonas reinhardtii. Cytoskeleton 2010, 67, 56-69.
134. Iomini, C.; Li, L.Y.; Esparza, J.M.; Dutcher, S.K. Retrograde intraflagellar transport mutants identify complex a proteins with multiple genetic interactions in chlamydomonas reinhardtii. Genetics 2009, 183, 885-896.
135. Manning, A.L.; Bakhoum, S.F.; Maffini, S.; Correia-Melo, C.; Maiato, H.; Compton, D.A. CLASP1, astrin and Kif2b form a molecular switch that regulates kinetochore-microtubule dynamics to promote mitotic progression and fidelity. EMBO J. 2010, 29, 3531-3543.
136. Thompson, S.L.; Bakhoum, S.F.; Compton, D.A. Mechanisms of chromosomal instability. Curr. Biol. 2010, 20, R285-R295.
137. Compton, D.A. Mechanisms of aneuploidy. Curr. Opin. Cell Biol. 2011, 23, 109-113.
138. Thompson, S.L.; Compton, D.A. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J. Cell Biol. 2010, 188, 369-381.
139. Su, Y.A.; Yang, J.; Tao, L.; Nguyen, H.; He, P. Undetectable and decreased expression of KIAA1949 (Phostensin) encoded on chromosome 6p21.33 in human breast cancers revealed by transcriptome analysis. J. Cancer 2010, 1, 38-50.
140. Mishra, R.K.; Chakraborty, P.; Arnaoutov, A.; Fontoura, B.M.A.; Dasso, M. The Nup107-160 complex and gamma-TuRC regulate microtubule polymerization at kinetochores. Nat. Cell Biol. 2010, 12, 164-169.
141. Weinger, J.S.; Qiu, M.H.; Yang, G.; Kapoor, T.M. A nonmotor microtubule binding site in Kinesin-5 is required for filament crosslinking and sliding. Curr. Biol. 2011, 21, 154-160.
142. Ems-McClung, S.C.; Walczak, C.E. Kinesin-13s in mitosis: Key players in the spatial and temporal organization of spindle microtubules. Semin. Cell Dev. Biol. 2010, 21, 276-282.
143. Sardar, H.S.; Luczak, V.G.; Lopez, M.M.; Lister, B.C.; Gilbert, S.P. Mitotic kinesin CENP-E promotes microtubule plus-end elongation. Curr. Biol. 2010, 20, 1648-1653.
144. Cai, S.; Weaver, L.N.; Ems-McClung, S.C.; Walczak, C.E. Proper organization of microtubule minus ends is needed for midzone stability and cytokinesis. Curr. Biol. 2010, 20, 880-885.
145. Walczak, C.E.; Cai, S.; Khodjakov, A. Mechanisms of chromosome behaviour during mitosis. Nat. Rev. Mol. Cell Biol. 2010, 11, 91-102.
146. Mackay, D.R.; Makise, M.; Ullman, K.S. Defects in nuclear pore assembly lead to activation of an Aurora B-mediated abscission checkpoint. J. Cell Biol. 2010, 191, 923-931.
147. Mackay, D.R.; Elgort, S.W.; Ullman, K.S. The nucleoporin Nup153 has separable roles in both early mitotic progression and the resolution of mitosis. Mol. Biol. Cell 2009, 20, 1652-1660.
148. Pollock, C.; Daily, K.; Van, T.N.; Wang, C.; Lewandowska, M.A.; Bensaude, O.; Huang, S. Characterization of MRP RNA-protein interactions within the perinucleolar compartment. Mol. Biol. Cell 2011, 22, 858-867.
149. Pollock, C.; Huang, S. The perinucleolar compartment. Cold Spring Harb. Perspect. Biol. 2010, 2, a000679.
150. Worman, H.J.; Ostlund, C.; Wang, Y.X. Diseases of the nuclear envelope. Cold Spring Harb. Perspect. Biol. 2010, 2, a000760.
151. Franke, J.D.; Montague, R.A.; Kiehart, D.P. Nonmuscle myosin II is required for cell proliferation, cell sheet adhesion and wing hair morphology during wing morphogenesis. Dev. Biol. 2010, 345, 117-132.
152. Shin, M.E.; He, Y.A.; Li, D.; Na, S.S.; Chowdhury, F.; Poh, Y.C.; Collin, O.; Su, P.; de Lanerolle, P.; Schwartz, M.A., et al. Spatiotemporal organization, regulation, and functions of tractions during neutrophil chemotaxis. Blood 2010, 116, 3297-3310.
153. Charest, P.G.; Shen, Z.X.; Lakoduk, A.; Sasaki, A.T.; Briggs, S.P.; Firtel, R.A. A ras signaling complex controls the RasC-TORC2 pathway and directed cell migration. Dev. Cell 2010, 18, 737-749.
154. Lee, S.; Shen, Z.X.; Robinson, D.N.; Briggs, S.; Firtel, R.A. Involvement of the cytoskeleton in controlling leading-edge function during chemotaxis. Mol. Biol. Cell 2010, 21, 1810-1824.
155. Palmer, S.M.; Playford, M.P.; Craig, S.W.; Schaller, M.D.; Campbell, S.L. Lipid binding to the tail domain of vinculin specificity and the role of the n and c termini. J. Biol. Chem. 2009, 284, 7223-7231.
156. Lue, N.F. Plasticity of telomere maintenance mechanisms in yeast. Trends Biochem. Sci. 2010, 35, 8-17.
157. Yu, E.Y.; Yen, W.F.; Steinberg-Neifach, O.; Lue, N.F. Rap1 in Candida albicans: An unusual structural organization and a critical function in suppressing telomere recombination. Mol. Cell. Biol. 2010, 30, 1254-1268.
158. Riggins, R.B.; Mazzotta, M.M.; Maniya, O.Z.; Clarke, R. Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response. Endocr. Relat. Cancer 2010, 17, R213-R231.